UK MedTech Strolll secures €5 million in Innovate UK funding and additional IW Capital-led investment
Article excerpt
Highlighted: the sentence this signal was extracted from
Strolll , a Stafford-based software-as-a-medical-device (SaMD) company using Augmented Reality for neurorehabilitation, has secured a new round of investment led by IW Capital, with participation from Cleveland Clinic and Future Planet Capital Regional. Additionally, Innovate UK has separately provided the company with a €4.18 million (£3.6 million) innovation loan and an €813.2k (£700k) Growth Catalyst Investor Partnerships (GCIP) award. The two awards fund two distinct projects and together provide €5 million (£4.3 million) in funding for Strolll. In March 2025, the company raised a €12.2 million Series A funding round led by IW Capital. Jorgen Ellis, CEO and co-founder of Strolll, said, "Our team is committed to revolutionising rehabilitation for those living with neurological disorders. This funding will help us accelerate our mission to increase patient engagement, support progression and help clinicians deliver effective neurorehabilitation to a wider patient population." Founded in 2018, Strolll is a MedTech startup that develops digital therapeutics software delivered via AR glasses to provide clinically proven and patented neurorehabilitation to patients living with neurological disorders. It supports therapy in both clinic and home settings. According to the company, the neurorehabilitation market is growing as more people need access to rehabilitation and ongoing...
Keep reading with a free account
The rest of this article, and every signal for Cleveland Clinic, is in your free account.
